Crossmark Global Holdings’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
RI
ACM
SI
Crossmark Global Holdings's RGNX Position: Q4 2021 in Review
Crossmark Global Holdings sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 9,350 shares — an estimated $392K sold.
Crossmark Global Holdings first reported a position in RGNX in Q3 2018 and held it in 8 quarters. The position peaked at $403K in Q4 2020. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.
- Crossmark Global Holdings reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
- Crossmark Global Holdings sold 9,350 Regenxbio shares in Q4 2021, an estimated $392K.
- Crossmark Global Holdings first reported a position in Regenxbio in Q3 2018 and held it in 8 quarters.
- Crossmark Global Holdings's Regenxbio position peaked at $403K in Q4 2020.
- 172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.
Based on Crossmark Global Holdings's 13F filing for Q4 2021, filed 10 Jan 2022.